Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001013594-25-000311·Madison Avenue Partners, LP
Schedule 13G ownership disclosure
Ovid therapeutics, Inc.
Common Stock, par value $0.001 per share (the "Common Stock") · CUSIP: 690469101
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Madison Avenue Partners, LP
Shares: 2,852,352 · Class: 4%
- Madison Avenue International LP
Shares: 2,852,352 · Class: 4%
- EMAI Management, LLC
Shares: 2,852,352 · Class: 4%
- Madison Avenue GP, LLC
Shares: 2,852,352 · Class: 4%
- Caraway Jackson Investments LLC
Shares: 2,852,352 · Class: 4%
- Eli Samaha
Shares: 2,852,352 · Class: 4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001013594-25-000311
- Form type
- SCHEDULE 13G/A
- Filer
- Madison Avenue Partners, LP
- CIK
- CIK 1801265
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership